These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17679658)

  • 1. The current revolution in newborn screening: new technology, old controversies.
    Tarini BA
    Arch Pediatr Adolesc Med; 2007 Aug; 161(8):767-72. PubMed ID: 17679658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening: current status.
    Arn PH
    Health Aff (Millwood); 2007; 26(2):559-66. PubMed ID: 17339686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of newborn screening in the era of tandem mass spectrometry: what's new for the pediatric neurologist?
    Copeland S
    Semin Pediatr Neurol; 2008 Sep; 15(3):110-6. PubMed ID: 18708000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded newborn screening in Oklahoma.
    Dannaway DC
    J Okla State Med Assoc; 2009 Feb; 102(2):50-3. PubMed ID: 19275072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of newborn screening: decision-making about the conditions to include in screening programs.
    Watson MS
    Ment Retard Dev Disabil Res Rev; 2006; 12(4):230-5. PubMed ID: 17183572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U.S. newborn screening policy dilemmas for the twenty-first century.
    Therrell BL
    Mol Genet Metab; 2001; 74(1-2):64-74. PubMed ID: 11592804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. California's experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry.
    Feuchtbaum L; Lorey F; Faulkner L; Sherwin J; Currier R; Bhandal A; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S261-9. PubMed ID: 16735252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for treatable genetic conditions: past, present and future.
    Hiraki S; Green NS
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):11-21. PubMed ID: 20494254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mass neonatal screening using biological testing].
    Ardaillou R; Le Gall JY;
    Gynecol Obstet Fertil; 2007 Apr; 35(4):367-74. PubMed ID: 17400505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mandatory versus voluntary consent for newborn screening?
    Ross LF
    Kennedy Inst Ethics J; 2010 Dec; 20(4):299-328. PubMed ID: 21338027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening: new developments, new dilemmas.
    Kerruish NJ; Robertson SP
    J Med Ethics; 2005 Jul; 31(7):393-8. PubMed ID: 15994357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.
    Bailey DB; Skinner D; Davis AM; Whitmarsh I; Powell C
    Pediatrics; 2008 Mar; 121(3):e693-704. PubMed ID: 18310190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scene from the USA: the illogic of mandating screening without also providing for treatment.
    Buist NR; Huntington K
    J Inherit Metab Dis; 2007 Aug; 30(4):445-6. PubMed ID: 17805992
    [No Abstract]   [Full Text] [Related]  

  • 15. A vision of the future of newborn screening.
    Alexander D; van Dyck PC
    Pediatrics; 2006 May; 117(5 Pt 2):S350-4. PubMed ID: 16735262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of newborn screening.
    Levy PA
    J Dev Behav Pediatr; 2010 Sep; 31(7):622-31. PubMed ID: 20814260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Talking with parents before newborn screening.
    Clayton EW
    J Pediatr; 2005 Sep; 147(3 Suppl):S26-9. PubMed ID: 16202778
    [No Abstract]   [Full Text] [Related]  

  • 18. Universal newborn screening and adverse medical outcomes: a historical note.
    Brosco JP; Seider MI; Dunn AC
    Ment Retard Dev Disabil Res Rev; 2006; 12(4):262-9. PubMed ID: 17183576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry in newborn and metabolic screening: historical perspective and future directions.
    Chace DH
    J Mass Spectrom; 2009 Feb; 44(2):163-70. PubMed ID: 19034889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Generalized neonatal screening based on laboratory tests].
    Ardaillou R; Le Gall JY
    Bull Acad Natl Med; 2006 Nov; 190(8):1745-59. PubMed ID: 17650757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.